Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q1 2025 Earnings

20MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.32

-0.29

-0.25

-0.22

Details

Expected EPS

-0.28199143115

Actual EPS

-0.221052

Surprise EPS

0.06

Surprise Percent

+21.61%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.221052 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.